"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"
Get your pass now until price go up & save 40%
Stanley Plotkin, MD
Consultant and Emeritus Professor, University of Pennsylvania, Vaxconsult, LLP
Kizzmekia S. Corbett, Ph.D
Assistant Professor of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
Roxana Rustomjee, MB, ChB, FCPHM, MMed, PhD
Senior Vice President, Research & Development, Sabin Vaccine Institute
David Weiner, M.D., Ph.D.
Executive Vice President, Director, Vaccine & Immunotherapy Center,
The Wistar Institute
Jay A. Berzofsky, M.D., Ph.D.
Chief, Vaccine Branch,
Center for Cancer Research,
National Cancer Institute
Farshad Guirakhoo, Ph.D.
Chief Scientific Officer, Vaxxinity
Samir N. Khleif, M.D.
Director, Jeannie and Tony Loop Immuno-Oncology Research Laboratory, Lombardi Comprehensive Cancer Center
Raches Ella, MBBS, MS
Head - Business Development & Advocacy, Bharat Biotech
Stephen L. Hoffman, M.D.
Chief Executive and Scientific Officer
Larry Corey, MD
Past President and Director Emeritus, Fred Hutch, Professor, Vaccine and Infectious Disease Division, Fred Hutch
Karen A. Norris, Ph.D.
Professor, Georgia Research Alliance Eminent Scholar, Charles H. Wheatley Chair in Immunology and Translational Biomedical Research, Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of GeorgiaPresentation Title
Paolo Lusso, M.D., Ph.D
Chief, Viral Pathogenesis, Laboratory of Immunoregulation, NIAID/NIH,
Andrew Lees, Ph.D.
CEO/CSO, Fina Biosolutions
Yongjun Sui, Ph.D.
Associate Scientist, Vaccine Branch, Center for Cancer Research, National Cancer Institute
Joost Oppenheim, M.D.
Senior Investigator, Head Cellular Immunology Section, Center for Cancer Research, National Cancer Institute
Mark J. Newman, Ph.D.
Chief Scientific Officer, GeoVax Inc
Thomas Tillett, Ph.D.
CEO, MBF Therapeutics
Kevin P. Killeen, Ph.D.
Sean M. Sullivan, Ph.D.
Executive Director, Process Science & Technology, Arcturus Therapeutics, Inc.
Louis D. Falo, Jr., M.D., Ph.D.
Chairman, Department of Dermatology, University of Pittsburgh School of Medicine
Dan Barouch, M.D., Ph.D
William Bosworth Castle Professor of Medicine, Harvard Medical School, Director, Center for Virology and Vaccine Research, BIDMC
Daniela Weiskopf, M.D., Ph.D
Research Assistant Professor, La Jolla Institute for Immunology
Kwong Tsang, Ph.D
CSO, Precision Biologics, Inc
Kevin O. Saunders, Ph.D
Associate Professor, Department of Surgery, Director, Laboratory of Protein Expression, Duke Human Vaccine Institute
Sukrit Srivastava, Ph.D
Research Group Leader, Infection Biology Group, Indian Foundation for Fundamental Research
David Weinreich, M.D., MBA
Executive Vice President, Regeneron Pharmaceuticals, Inc, Head of Global Clinical Development, Co-Head of Global Development
Marie-Claire Gauduin, Ph.D.
Associate Professor, Disease Intervention and Prevention, Core Scientist, Southwest National Primate Research Center, Texas Biomedical Research Institute
In-Jeong Kim, Ph.D.
Principal Investigator, Viral Immunity Division, Trudeau Institute Inc
Robert O. Dillman, M.D.
Chief Medical Officer, AIVITA Biomedical, Inc
Charlotte Thalin, Ph.D.
Jim Koopman, M.D., MPH
Developing Theory that Serves the Public Health
David E. Wentworth, Ph.D.
Director, WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Branch Chief, Virology Surveillance and Diagnosis, CDC
Jerald C. Sadoff, Ph.D.
Senior Advisor, Janssen
Bert Jacobs, Ph.D.
Professor, School of Life Sciences, Member, Biodesign Center for Immunotherapy, Vaccines and Virotherapy, Arizona State University
Steven P. Fling, Ph.D.
Sr. Staff Scientist, Fred Hutch, CITN Lab Director
Nicolas Çuburu, Ph.D.
Staff Scientist, Laboratory of Cellular Oncology, Center for Cancer Research, NCI
Baochun Zhang, MB, Ph.D.
Assistant Professor, Harvard Medical School, Division of Hematologic Neoplasia, Department of Medical Oncology, Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute
Pragya D Yadav, M.Sc., Ph.D
Scientist 'E' and Group Leader, Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology
Allen (Chia En) Lien, M.D., DrPH
VP, International and Governmental Affairs, MEDIGEN VACCINE BIOLOGICS CORP
Vjollca Konjufca, Ph.D
Associate Professor, Southern Illinois University
Daniel Kulp, Ph.D
Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute
Tomáš Hanke, Ph.D
The Jenner Institute, Nuffield Department of Medicine, University of Oxford
Jiang Zhu, Ph.D
Associate Professor, Integrative Structural and Computational Biology, Immunology and Microbiology, The Scripps Research Institute
Alexandre Le Vert, Ph.D
Chairman, CEO and Cofounder, OSIVAX
Masfique Mehedi, Ph.D
Assistant Professor, Dept. of Biomedical Sciences, School of Medicine & Health Sciences,Univer sity of North Dakota
Shahin Gharakhanian, MD, DPH
Pharmaceutical Medicine, Infectious Diseases, Shahin Gharakhanian MD Consulting LLC, CIC: Cambridge Innovation Center
Geoffrey Lynn, Ph.D
SVP, Synthetic Immunotherapies, Vaccitech
Mark Connors, M.D
Chief, HIV-Specific Immunity Section, NIAID/LIR
Ouzama Henry, MD, MSc
Vice President and Head, Clinical R&D, Rockville Center for Vaccine Research, GSK
Mohan Karkada, Ph.D.
Director of Research & Development, Immunomic Therapeutics, Inc.
Ashima Shukla, Ph.D.
CSO and co-founder, Styx Biotechnologies Inc
Dahlene Fusco, MD, PhD
Assistant Professor of Medicine, Tulane University School of Medicine
Martha Alexander-Miller, MD, PhD
Professor and Chair, Dept. of Microbiology and Immunology, Director Center for Vaccines at the Extremes of Aging, Wake Forest School of Medicine
Robert Carnahan, PhD
Associate Director, Vanderbilt Vaccine Center
Petro Terblanche, PhD
Managing Director: Afrigen Biologics
Tomas Hanke, PhD
The Jenner Institute, Nuffield Department of Medicine, University of OxfordPresentation Title
Philip R Krause
Former FDA Deputy Director, Office of Vaccines Research and Review, Consultant, World Health OrganizationPresentation Title
Theodore (Ted) Schenkelberg, MBA, MPH
Senior Vice President and Chief Strategy Officer, Human Vaccines Project